Company intelligence / Profile preview

Heilongjiang Aolida Naide Pharmaceutical

Harbin, Heilongjiang, China

Ownership: Private
Development stage: Other

Overview

Heilongjiang Aolida Naide Pharmaceutical is a pharmaceutical manufacturing enterprise located in the Limin Development Zone of Harbin, China. As a core member of the Heilongjiang Aolida Pharmaceutical Group, the company specializes in the production of chemical raw materials and finished dosage forms, including large and small volume injections, tablets, and capsules. Its product line is diverse, featuring anti-viral agents, cardiovascular medications, and antibiotics. The company operates GMP-certified facilities and maintains a significant presence in the domestic Chinese healthcare market.

Therapeutic areas: Infectious DiseasesGastroenterologyCardiovascular
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Heilongjiang Aolida Naide Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Heilongjiang Aolida Naide Pharmaceutical.

Explore the full profile